This service is available in real time upon request with a 30-minute notice 24/7/365.

Accomplished Former GE Chief Financial Officer Michi Sassa Joins Company

Novel NRCT-101SR shown in previous human studies to be effective and well-tolerated with no side effects

Brin to serve on National Advisory Neurological Disorders and Stroke Council

Recent advances in biomolecular medicine and biotechnology will make it possible for the injured brain to regenerate.

The nootropics site WholisticResearch just announced they bought the domain MyBrainTrainer.com, which was previously a virtual mental gym for brain exercises.

CorInsights MRI Provides Exceptional Insight Using Brain Volume Quantitation

Arterys Partners with Combinostics To Offer The Most Comprehensive Neuro AI Suite On The Market Covering A Broad Set of Applications In Neuroradiology

ALLM AND SVIN MT2020+ — TRANSFORMING STROKE CARE TOGETHER

CNF Makes Community-Wide Call to Join Them in Next 20 Campaign

Class Action Lawsuit was Filed in 2007 on Behalf of People with ABI who were Institutionalized and Preferred to Live in High-Quality, More Integrated Community Settings

Future Efforts Expanded to Support Medical Professionals, Helping Children and Families Living With a Neurologic Condition Get the Best Quality of Care Possible

New 35,000 square foot Facility will support the company's growth and OUS expansion

Following recent FDA approval of Biogen's Alzheimer antibody drug ADUHELM (TM), targeting oligomers of amyloid beta, Galimedix aims for first patients with its GAL-201 oral small molecule drug within one year.

HEDscan is the world's first, commercially available, non-cryogenic, whole-head MEG system designed to expand the research and diagnosis of a broad range of mental health diseases

Functional Neurological approach used at Oculus Brain Centers(TM) in San Diego rewires the brain through adaptive treatment strategies

A new approach to help each person to obtain optimal biological resiliency.

Dr. Mark L. Gordon of Millennium Health Centers, Inc. discusses the science supporting neuroinflammation as a contributing factor to mental illness.

A Non-Traumatic Brain Injury Called Viral Encephalopathy

Two-Part Series: Adults and Children Living with Hydrocephalus

European neurostimulation devices market will register 16% CAGR up to 2025, driven by presence of prominent market players focusing on R&D of technologically driven products.

Asia Pacific neurovascular devices market revenue exceeded USD 600 million in 2018 and is set to register healthy CAGR from 2019 to 2025, owing to rising awareness regarding advanced and innovative neurovascular devices.

Distinguished Vascular Researcher Says College Findings Appear 'Highly Biased and Improper'